MYRA BLANKENSHIP: Open Payments
NPI 1760668271 · KINGSPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,618 in 121 payments from 42 companies in 2025. Trend: 2023 $763 · 2024 $824 · 2025 $3,618
Food & beverage: $3,418Education: $100Long term medical supply or device loan: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $355 |
| Daiichi Sankyo Inc. | 8 | $262 |
| Lilly USA, LLC | 3 | $180 |
| Karyopharm Therapeutics Inc. | 3 | $176 |
| E.R. Squibb & Sons, L.L.C. | 4 | $176 |
| Janssen Biotech, Inc. | 5 | $172 |
| Regeneron Healthcare Solutions, Inc. | 4 | $163 |
| Iovance Biotherapeutics, Inc. | 2 | $145 |
| Incyte Corporation | 5 | $122 |
| AstraZeneca Pharmaceuticals LP | 5 | $122 |
Products named: KISQALI, Enhertu, REBLOZYL, XPOVIO, LIBTAYO, Amtagvi, Lenvima, EPKINLY.
Industry payments across TN — which companies pay providers there.
